ArticleCureus2025
A Rare Case of Aggressive Tongue Malignant Melanoma: Clinical Presentation and Treatment Approach.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tongue malignant melanoma is a very rare and highly aggressive subtype of oral mucosal melanoma (OMM), often diagnosed at advanced stages due to its asymptomatic course and rapid progression. This case report describes a 69-year-old female who presented with a progressively enlarging lesion on the ventral surface of her tongue, present for 10 years. Diagnosis of spindle cell malignant melanoma was confirmed by incisional biopsy, and staging revealed right cervical lymph node involvement without distant metastasis. The patient underwent hemiglossectomy, comprehensive neck dissection, and reconstructive surgery, followed by adjuvant radiotherapy (RT) with a simultaneous integrated boost (SIB) delivering 60 Gy to the surgical bed and high-risk lymph nodes and 54 Gy to contralateral low-risk lymphatics. Despite achieving initial local control (LC), aggressive distant metastases, including mediastinal lymph nodes, bilateral lung nodules, and bone lesions, rapidly developed within three months post-RT. Genetic analysis revealed no BRAF mutation, thus limiting targeted therapeutic options. This case underscores the significant diagnostic and therapeutic challenges posed by tongue malignant melanoma, emphasizing its aggressive biological behavior and high metastatic potential. A multidisciplinary approach combining radical surgery and adjuvant RT is crucial; however, the rapid distant progression highlights the critical need for more effective systemic treatment options and the integration of genetic profiling to guide personalized therapies. Further comprehensive research is essential to optimize management strategies and improve the limited survival outcomes associated with this rare and challenging malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.